InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,720.34
(
-0.22%
)
US TECH 100
19,410.40
(
-0.02%
)
Dow Jones
41,912.01
(
-0.70%
)
Brent Oil
72.77
(
-2.41%
)
Bitcoin
63,176.47
(
-1.68%
)
Post# of 38152
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

budfoxfun

Send PM Follow Ignore
Followers 972
Posts 383067
Boards Moderated 5
Alias Born 06/24/2011

budfoxfun

Re: None

Wednesday, 04/18/2018 1:19:12 PM

Wednesday, April 18, 2018 1:19:12 PM

Post# of 38152
$BCTXF BriaCell Therapeutics Corp. ("BriaCell") (BCT.V) (BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that it has presented two posters highlighting its most recent scientific and clinical findings of BriaCell’s lead product candidate, SV-BR-1-GM, also known as Bria-IMT™, at the 2018 American Association of Cancer Research (AACR) Annual Meeting. The posters are available for viewing at http://briacell.com/category/recent-events/.

News: BriaCell Provides Highlights of Scientific and Clinical Findings at AACR https://finance.yahoo.com/news/briacell-provides-highlights-scientific-clinical-133000708.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up